Cromos™ Pharma is a premier regional CRO in the countries of Central and Eastern Europe, former Soviet republics and Israel

News
A premier regional contract-research organization (CRO) for clinical outsourcing to Russia, Ukraine, Belarus, Georgia, Eastern Europe,Lithuania, Baltic states, Estonia, Latvia, Israel.

Cromos Pharma is a regional contract research organization (CRO) that specializes in biopharmaceutical clinical outsourcing to Russia, Ukraine, Belarus, Georgia, countries of Eastern Europe and Israel – areas with very compelling environment for biopharmaceutical research. The company manages Phase I-IV clinical trials, bioequivalence and observational studies and has been successfully operating since 2004.

Our business model is a product of the most validated Western solutions which are carefully tailored to local environments.

Full compliance with ICH GCP regulations, motivated and experienced investigators with impeccable reputations, large patient population is the integral to our ability to provide high quality and affordable services.

As project managers, our "cum laude" MDs and PhDs don't just flawlessly adhere to a study protocol, they appreciate the science behind it. By choosing Cromos Pharma you get an invariable guarantee that your project will be handled by the "A-team".

In 2012 Cromos Pharma has adopted a fully integrated, cloud-based, virtual workplace model. This has allowed for seamless integration of all offices and employees, significantly increased the company's productivity and reduced its overhead.

Cromos Pharma offers budget-friendly clinical outsourcing solutions via innovative operational structure and project-specific alliances. We guarantee speed, quality, and best experts in the field. Our intricate knowledge of the market, long-term working relationship and personal ties with the best research centers and health care authorities translate into a unique capability to accomplish the most difficult tasks.

Please, contact us to learn more about Cromos Pharma clinical trial services.

 


Join us at the 3rd Annual Clinical Trial Oversight Summit where Cromos Pharma's CEO, Dr. Vlad Bogin will give a talk on implementation of risk-based monitoring in international clinical trials
 
Cromos Pharma's CEO, Dr. Vlad Bogin will be speaking at Clinical Trial Oversight Summit that takes place in Boston, USA on 2-5 June 2014 / 09.04.2014
Cromos Pharma presented an update on the status of clinical trials in Ukraine / 25.03.2014
Cromos Pharma at Partnerships in Clinical Trials Conference in Las Vegas, USA on 30 March – 02 April 2014 / 14.03.2014
Cromos Pharma has successfully completed the inspection by RosZdravNadzor, the Russian state regulatory agency. / 05.02.2014